SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-041503
Filing Date
2024-02-21
Accepted
2024-02-21 16:29:08
Documents
14
Period of Report
2024-02-16
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K d796578d8k.htm   iXBRL 8-K 29349
  Complete submission text file 0001193125-24-041503.txt   155313

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pkbo-20240216.xsd EX-101.SCH 2499
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pkbo-20240216_lab.xml EX-101.LAB 18699
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pkbo-20240216_pre.xml EX-101.PRE 11676
16 EXTRACTED XBRL INSTANCE DOCUMENT d796578d8k_htm.xml XML 3883
Mailing Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588
Business Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588 (925) 463-4800
Peak Bio, Inc. (Filer) CIK: 0001834645 (see all company filings)

IRS No.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39951 | Film No.: 24660043
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)